SOCFINASIA S.A. financials
SOCFINASIA S.A.
Country: LU Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
222100I5M4DM5G5NES09 Financial statements
(EUR, as reported — unscaled; 104 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €186.4M | €178.5M |
| Other income | €808.2K | €1.5M |
| Employee benefits expense | €70.6M | €65.0M |
| Raw materials & consumables used | €17.5M | €23.4M |
| Operating profit (EBIT) | €76.3M | €62.0M |
| Finance costs | €8.1M | €7.5M |
| Profit before tax | €87.2M | €65.5M |
| Profit for the year | €67.2M | €51.7M |
| — attributable to owners | €60.9M | €46.1M |
| — attributable to NCI | €6.3M | €5.6M |
| Total comprehensive income | €72.5M | €48.3M |
| Per share | ||
| Basic EPS | €3.11 | €2.35 |
| Diluted EPS | €3.11 | €2.35 |
| Cash flow statement | ||
| Net cash from operating activities | €81.1M | €62.8M |
| Net cash from investing activities | €39.4M | €58.9M |
| Net cash from financing activities | -€86.4M | -€101.3M |
| Dividends paid | €42.7M | €32.1M |
| Proceeds from borrowings | €0 | €3.1K |
| Repayments of borrowings | €0 | €27.5M |
| Lease liability payments | €27.9K | €27.7K |
| Balance sheet | ||
| Total assets | €361.2M | €363.4M |
| Non-current assets | €184.1M | €217.6M |
| Property, plant & equipment | €41.8M | €39.2M |
| Right-of-use assets | €3.6M | €2.7M |
| Current assets | €177.1M | €145.8M |
| Inventories | €21.8M | €16.9M |
| Trade & other receivables | €1.5M | €2.3M |
| Cash & equivalents | €149.0M | €114.6M |
| Total equity | €242.5M | €255.6M |
| — attributable to owners | €235.6M | €247.9M |
| Non-controlling interests | €6.9M | €7.7M |
| Non-current liabilities | €39.2M | €38.5M |
| Lease liabilities (non-current) | €350.2K | €356.6K |
| Current liabilities | €79.6M | €69.3M |
| Lease liabilities (current) | €29.1K | €27.3K |
| Deferred tax liabilities | €3.9M | €3.6M |
| Derived metrics | ||
| Operating margin | 40.9% | 34.7% |
| Net margin | 36.0% | 29.0% |
| Return on equity | 27.7% | 20.2% |
| Cash conversion ratio | 1.21× | 1.21× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€5.1M | €765.9K |
| Adjustments For Decrease Increase In Trade and Other Receivables | €13.5M | €3.6M |
| Adjustments For Fair Value Gains Losses | €526.3K | -€1.2M |
| Adjustments For Income Tax Expense | €24.6M | €19.7M |
| Adjustments For Increase Decrease In Trade and Other Payables | €5.5M | €9.5M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €135.8K | €1.0M |
| Adjustments For Undistributed Profits of Associates | €4.6M | €5.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €96.4M | €85.7M |
| Changes In Inventories of Finished Goods and Work In Progress | -€4.2M | €704.3K |
| Comprehensive Income Attributable To Noncontrolling Interests | €6.4M | €5.4M |
| Comprehensive Income Attributable To Owners of Parent | €66.1M | €42.9M |
| Current Biological Assets | €1.6M | €1.4M |
| Current Tax Assets Current | €1.2M | €743.6K |
| Current Tax Expense Income | €24.5M | €20.1M |
| Current Tax Liabilities Current | €8.0M | €2.2M |
| Deferred Tax Assets | €5.5M | €5.1M |
| Deferred Tax Expense Income | €87.4K | -€412.2K |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €7.7M | €10.8M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €78.4M | €68.6M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €7.2M | €4.1M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €5.00 | — |
| Dividends Received Classified As Operating Activities | €3.5M | €8.3M |
| Dividends Recognised As Distributions To Owners Per Share | €4.00 | €3.50 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €280.8K | -€462.6K |
| Equity and Liabilities | €361.2M | €363.4M |
| Finance Income | €19.1M | €12.1M |
| Gains On Disposals of Noncurrent Assets | €32.3K | €0 |
| Income Tax Relating To Changes In Revaluation Surplus of Other Comprehensive Income | -€7.8K | -€10.5K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€7.6K | -€132.9K |
| Income Taxes Paid Refund Classified As Operating Activities | €20.7M | €27.9M |
| Increase Decrease In Cash and Cash Equivalents | €34.5M | €19.9M |
| Increase Decrease In Working Capital | -€12.2M | -€12.8M |
| Increase Decrease Through Transactions With Owners | -€85.6M | -€72.7M |
| Increase Decrease Through Transfers and Other Changes Equity | -€22.4K | €9.2K |
| Intangible Assets Other Than Goodwill | €330.7K | €301.9K |
| Interest Paid Classified As Financing Activities | €761.1K | €1.1M |
| Interest Received Classified As Investing Activities | €7.5M | €8.9M |
| Investments In Associates Accounted For Using Equity Method | €27.2M | €22.7M |
| Issued Capital | €24.5M | €24.5M |
| Losses On Disposals of Noncurrent Assets | €168.1K | €1.0M |
| Noncurrent Biological Assets | €100.3M | €91.8M |
| Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income | €5.3M | €5.2M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €34.9M | €34.5M |
| Other Adjustments For Noncash Items | -€2.3M | €1.3M |
| Other Comprehensive Income | €5.3M | -€3.5M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€34.8K | -€604.0K |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | -€26.0K | -€42.3K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €5.3M | -€2.6M |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | -€18.1K | -€31.7K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€27.1K | -€471.1K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €5.3M | -€2.9M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€45.3K | -€502.9K |
| Other Current Payables | €62.4M | €59.7M |
| Other Current Receivables | €2.1M | €9.9M |
| Other Expense By Nature | €394.0K | €1.0M |
| Payments From Changes In Ownership Interests In Subsidiaries | €5.6K | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €829.9K | €661.5K |
| Reserve of Exchange Differences On Translation | -€119.8M | -€125.0M |
| Retained Earnings Profit Loss For Reporting Period | €60.9M | €46.1M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | -€337.9K |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €4.6M | €5.9M |
| Statutory Reserve | €2.4M | €2.4M |
| Trade and Other Current Payables To Trade Suppliers | €9.2M | €7.3M |
| Weighted Average Shares | 19.6M | 19.6M |
Methodology
Every line item above is a fact tagged in SOCFINASIA S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.